Simufilam is an experimental medication for the treatment of Alzheimer's disease. It was being developed by the American pharmaceutical firm Cassava Sciences. From Wikipedia
The biotech firm’s experimental drug simufilam failed to demonstrate efficacy, leading to plummeting stock prices and a reevaluation of its future.
